ATEC insider trading

NasdaqGS Healthcare

Alphatec Holdings, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades
759
Last 90 days
3
Buys / sells
13% / 29%
Market cap
$1.65B

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Company website: www.atecspine.com

ATEC insider activity at a glance

FilingIQ tracks 759 insider transactions for ATEC in filings since Mar 31, 2015. The most recent transaction is dated Oct 5, 2026.

Across the full history, 100 open-market purchases and 221 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ATEC insider trades is 54.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest ATEC Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for ATEC?
FilingIQ tracks 759 Form 4 insider transactions for ATEC (Alphatec Holdings, Inc.), covering filings from Mar 31, 2015 onwards. 3 of those are dated within the last 90 days.
Are ATEC insiders net buyers or net sellers?
Across the full Form 4 history for ATEC, 100 transactions (13%) were open-market purchases and 221 (29%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ATEC insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is ATEC in?
Alphatec Holdings, Inc. (ATEC) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.65B.

Methodology & sources

Every ATEC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.